I think it all started with GSW and the ASX decided to seek clarification on some of the deals announced by MYQ.
The announcement states MYQ and Fitocracy have an initial TARGET of 500,000 users paying U$1.50 per month and generating annual revenue of U$9 million subject to this target being achieved.
The announcement also states that the parties have agreed to enter into a definitive agreement within 90 days to better define their roles and obligations. It’s now been over six months. Has the agreement been signed?
The research report (commissioned by MYQ) dated 6 December states that Fitocracy has COMMITED to growing the subscribers over the first 12 months to 500,000 monthly actives. This contradicts the previous announcement which mentioned this figure was only a target.
The share price target of $1.16 is to a great extent derived from this annual revenue of U$9 million and it is also assumed that MYQ will attract 200,000 subscribers by 30 June 2018 (is this even possible? They’ve shown zero app revenue so far which means zero subscribers).
The same research report estimates revenue of $17.9 million for the financial year ended 30 June 2018. IMO this is highly unlikely given there was no app revenue during the half year to December 2017 and so far no announcements have been made regarding the app being available through Fitocracy or the Mayweather Training App.
The company needs to update shareholders on the status of all these targets.
No doubt all these deals have great potential and this could be a $2 stock provided the revenue is there, otherwise we are back to where it started... As always DYOR!
- Forums
- ASX - By Stock
- AHI
- Ann: Trading Halt
Ann: Trading Halt, page-19
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AHI (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.77M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AHI (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online